Search

everythinglearnresearchcommunity

for

Search:↓

A woman with Kallman's syndrome also developed alopecia universalis, a condition not previously linked to Kallman's.

Microneedles combined with conventional therapies show promise in treating alopecia areata.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

Fractional CO2 laser with topical triamcinolone is more effective and safer for treating alopecia areata than intralesional triamcinolone.

In Germany, alopecia areata is common and often occurs with skin conditions like eczema and psoriasis, affecting women slightly more and varying by region.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Scalp rolling might help regrow hair in people with a hair loss condition called Alopecia Areata.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Understanding the genetics of alopecia areata could lead to better treatments.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Trichoscopy helps tell apart hair loss due to alopecia areata from trichotillomania in eyebrows.

Lupus erythematosus can mimic alopecia areata, and trichoscopy is key for accurate diagnosis and better patient outcomes.

Hair loss in both Androgenetic Alopecia and Alopecia Areata is often accompanied by inflammation around hair follicles, but the location and severity of this inflammation varies.

People with alopecia areata had lower vitamin D levels, but these levels didn't relate to many aspects of the condition.